UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 35 filers reported holding UNUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,866,000 | +408.8% | 3,361,535 | 0.0% | 8.14% | +392.2% |
| Q2 2020 | $1,546,000 | +12.2% | 3,361,535 | 0.0% | 1.65% | -43.3% |
| Q1 2020 | $1,378,000 | -43.1% | 3,361,535 | 0.0% | 2.91% | -30.9% |
| Q4 2019 | $2,420,000 | -50.0% | 3,361,535 | 0.0% | 4.22% | -47.1% |
| Q3 2019 | $4,840,000 | -45.0% | 3,361,535 | 0.0% | 7.97% | -15.4% |
| Q2 2019 | $8,807,000 | -40.3% | 3,361,535 | 0.0% | 9.42% | -32.1% |
| Q1 2019 | $14,757,000 | -0.2% | 3,361,535 | 0.0% | 13.86% | -18.6% |
| Q4 2018 | $14,791,000 | -57.3% | 3,361,535 | 0.0% | 17.03% | -7.1% |
| Q3 2018 | $34,624,000 | -28.2% | 3,361,535 | 0.0% | 18.32% | -13.7% |
| Q2 2018 | $48,238,000 | +29.2% | 3,361,535 | 0.0% | 21.23% | -24.8% |
| Q1 2018 | $37,347,000 | – | 3,361,535 | – | 28.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 3,361,535 | $4,840,000 | 7.97% |
| CHI Advisors LLC | 790,805 | $1,139,000 | 1.11% |
| New Leaf Venture Partners, L.L.C. | 1,795,545 | $2,586,000 | 0.78% |
| SECTORAL ASSET MANAGEMENT INC | 1,519,174 | $2,188,000 | 0.38% |
| Novo Holdings A/S | 473,441 | $682,000 | 0.12% |
| WEDBUSH SECURITIES INC | 33,135 | $48,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 100,000 | $144,000 | 0.00% |
| WASATCH ADVISORS LP | 254,449 | $366,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 21,602 | $31,000 | 0.00% |
| FIL Ltd | 783,423 | $1,128,000 | 0.00% |